Abstract
In human HIV infection, multinucleated cells (syncytia) are formed by fusion of HIV-infected cells with CD4+ cells. In order to examine possible functional implications of syncytia formation for the immune response, the expression of important surface molecules by T-cell syncytia and surrounding cells that remain unfused (bystander cells) was analyzed in cocultures of HIV-Env- and CD4-expressing E6 Jurkat T cells. Fusion partners were differentially labeled with lipophilic probes, and syncytia and bystander cells were identified by flow cytometry. The cellular phenotype and response to activation stimulus after fusion were analyzed with antibodies coupled to third-party fluorochromes. Cocultured unfused E6 cells showed a marked decrease in CD4 expression, suggesting the selective recruitment of cells strongly expressing CD4 into syncytia. However, the incorporated CD4 was not detected in the syncytia, whereas the range of expression of CD28, ICAM-1, CXCR4 and CD3 was wider than that of unfused cells. Limited expression of CD4 in the bystander unfused population, as well as in the newly formed syncytia, would result in limitation of further viral entry and a failure to identify these cells, and it could partially contribute to functional impairment and a decrease in the number of CD4+ T cells in AIDS. Most of the syncytia were viable and expressed CD25 and IL-2 in response to activation by phorbol myristate acetate (PMA) and ionomicyn. Thus, syncytia populations harboring widely heterogeneous levels of receptors would constitute a potential source of anomalous immune function.
Similar content being viewed by others
References
Lifson JD, Reyes GR, McGrath MS, Stein BS, Engleman EG (1986) AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science 232:1123–1127
Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA (1986) Role of the HTLV-III/LAV envelope syncytium formation and cytophaticity. Nature 322:470–474
Berger EA, Murphy PM, Farber JM (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17:657–700
Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR (1997) Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 185:621–628
Blaak H, van`t Wout AB, Brouwer M, Hooibrink B, Hovenkamp E, Schuitemaker H (2000) In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline. Proc Natl Acad Sci USA 97:1269–1274
Connor RI, Mohri H, Cao Y, Ho DD (1993) Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 67:1772–1777
Koot M, Keet IP, Vos AH, de Goede RE, Roos MT, Coutinho RA, Miedema F, Schellekens PT, Tersmette M (1993) Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Int Med 118:681–688
Fouchier RAM, Meyaard L, Brouwer M, Hovenkam EY, Schuitemaker H (1996) Broader tropism and higher cytopathicity for CD4+ T cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolate as a mechanism for accelerated CD4+ T cell decline in vivo. Virol 219:87–95
Miedema F, Meyaard L, Koot M, Klein MR, Roos MT, Groenink M, Fouchier RA, Van’t Wout AB, Tersmette M, Schellekens PT, Schuitemaker H (1994) Changing virus-host interactions in the course of HIV-1 infection. Immunol Rev 140:35–72
Furrer H, Wendland T, Minder C, Christen A, von Overbeck J, Grunow R, Pichler W, Malinverni RP (1998) Association of syncytium-inducing phenotype of HIV-1 with CD4 cell count, viral load and sociodemographic characteristics. AIDS 12:1341–1346
Etemad-Moghadam B, Rhone D, Steenbeke T, Sun Y, Manola J, Gelman R, Fanton JW, Racz P, Tenner-Racz K, Axthelm MK, Letvin NL, Sodroski J (2001) Membrane-fusing capacity of the human immunodeficiency virus envelope protein determines the efficiency of CD4+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus. J Virol 75:5646–5655
Nardacci R, Antinori A, Larocca LM, Arena V, Amendola A, Perfettini JL, Kroemer G, Piacentini M (2005) Characterization of cell death pathways in human immunodeficiency virus-associated encephalitis. Am J Pathol 167:695–704
Frankel SS, Tenner-Racz K, Racz P, Wenig BM, Hansen CH, Heffner D, Nelson AM, Pope M, Steinman RM (1997) Active replication of HIV-1 at the lymphoepithelial surface of the tonsils. Am J Pathol 151:89–96
Orenstein JM (2000) In vivo cytolysis and fusion of human immunodeficiency virus type 1-infected lymphocytes in lymphoid tissue. J Infect Dis 182:338–342
Teo I, Veryard C, Barnes H, An SF, Jones M, Lantos PL, Luthert P, Shaunak S (1997) Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS. J Virol 71:2928–29330
Castedo M, Perfettini JL, Andreau K, Roumier T, Piacetini M, Kroemer G (2003) Mitochondrial apoptosis induced by the HIV-1 envelope. Ann N Y Acad Sci 1010:19–28
Scheller C, Jassoy C (2001) Syncytium formation amplifies apoptotic signals: a new view on apoptosis in HIV infection in vitro. Virology 282:48–55
Rinfret A, Latendresse H, Lefebvre R, St-Louis G, Jolicoeur P, Lamarre L (1991) Human immunodeficiency virus-infected multinucleated histiocytes in oropharyngeal lymphoid tissues from two asymptomatic patients. Am J Pathol 138:421–426
Chan DC, Kim PS (1998) HIV entry and its inhibition. Cell 93:681–684
Berman PW, Nakamura GR (1994) Adhesion mediated by intercellular adhesion molecule 1 attenuates the potency of antibodies that block HIV-1 gp160-dependent syncytium formation. AIDS Res Hum Retroviruses 10:585–593
Hildreth JE, Orentas RJ (1989) Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 244:1075–1078
Pantaleo G, Butini L, Graziosi C, Poli G, Schnittman SM, Greenhouse J, Gallin JI, Fauci AS (1991) Human immunodeficiency virus (HIV) infection in CD4+ T-lymphocytes deficient in LFA-1: LFA-1 is required for HIV-mediated fusion but not for viral transmission. J Exp Med 173:511–514
Huerta L, Lamoyi E, Baez-Saldaña A, Larralde C (2002) Human immunodeficiency virus envelope-dependent cell–cell fusion: a quantitative fluorescent cytometric assay. Cytometry 47:100–106
Huerta L, López-Balderas N, Larralde C, Lamoyi E (2006) Discriminating in vitro cell fusion from cell aggregation by flow cytometry combined with fluorescence resonance energy transfer. J Virol Methods 138:17–23
López-Balderas N, Huerta L, Villarreal C, Rivera-Toledo E, Sandoval G, Larralde C, Lamoyi E (2007) In vitro cell fusion between CD4(+) and HIV-1 Env(+) T cells generates a diversity of syncytia varying in total number, size and cellular content. Virus Res 123:130–146
Gascoigne NR, Zal T (2004) Molecular interactions at cell-antigen-presenting cell interface. Curr Opin Immunol 16:114–119
Cao J, Park IW, Cooper A, Sodroski J (1996) Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1. J Virol 70:1340–1354
Huerta L, López-Balderas N, Rivera-Toledo E, Sandoval G, Gómez-Icazbalceta G, Villarreal C, Lamoyi E, Larralde C (2009) HIV-envelope-dependent cell-cell fusion: quantitative studies. ScientificWorld J 9:746–763
Schmid I, Uittenbogaart CH, Giorgi JV (1994) Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry. Cytometry 15:12–20
van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31:1–9
Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (2001) Current protocols in immunology. Greene Publishing, Wiley, New York
Crise B, Buonocore L, Rose JK (1990) CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J Virol 64:5585–5593
Stevenson M, Meier C, Mann A, Chapman N, Wasiak A (1988) Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS. Cell 53:483–496
Abraham RT, Weiss A (2004) Jurkat T cells and development of the T-cell receptor signaling paradigm. Nat Rev Immunol 4:301–308
Frey S, Marsh M, Günther S, Pelchen-Matthews A, Stephens P, Ortlepp S, Stegmann T (1995) Temperature dependence of cell–cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1. J Virol 69:1462–1472
Iyengar S, Hildreth JE, Schwartz DH (1998) Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells. J Virol 72:5251–5255
Moore JP, McKeating JA, Weiss RA, Sattentau QJ (1990) Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250:1139–1142
Schneider J, Kaaden O, Copeland TD, Oroszlan S, Hunsmann G (1986) Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus. J Gen Virol 67:2533–2538
Geleziunas R, Bour S, Wainberg MA (1994) Cell surface down-modulation of CD4 after infection by HIV-1. FASEB J 8:593–600
Dimitrov DS, Hillman K, Manischewitz J, Blumenthal R, Golding H (1992) Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein. J Virol 66:132–138
Hart TK, Kirsh R, Ellens H, Sweet RW, Lambert DM, Petteway SR Jr, Leary J, Bugelski PJ (1991) Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. Proc Natl Acad Sci USA 88:2189–2193
Bergeron L, Sullivan N, Sodroski J (1992) Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus. J Virol 66:2389–2397
Amadori A, De Silvestro G, Zamarchi R, Veronese ML, Mazza MR, Schiavo G, Panozzo M, De Rossi A, Ometto L, Mous J et al (1992) CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients. J Immunol 148:2709–2716
Mannie MD, Rosser JM, White GA (1995) Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell recognition. J Immunol 154:2642–2654
Viola A, Salio M, Tuosto L, Linkert S, Acuto O, Lanzavecchia A (1997) Quantitative contribution of CD4 and CD8 to T cell antigen receptor serial triggering. J Exp Med 186:1775–1779
Orenstein JM (2008) HIV expression in surgical specimens. AIDS Res Hum Retroviruses 24:947–955
Walter BL, Wehrly K, Swanstrom R, Platt E, Kabat D, Chesebro B (2005) Role of low CD4 levels in the influence of human immunodeficiency virus type 1 envelope V1 and V2 regions on entry and spread in macrophages. J Virol 79:4828–4837
Bhattacharya J, Peters PJ, Clapham PR (2003) CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivo. AIDS 17(Suppl 4):S35–S43
Puffer BA, Pöhlmann S, Edinger AL, Carlin D, Sanchez MD, Reitter J, Watry DD, Fox HS, Desrosiers RC, Doms RW (2002) CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity. J Virol 76:2595–2605
Cefai D, Ferrer M, Serpente N, Idziorek T, Dautry-Varsat A, Debre P, Bismuth G (1992) Internalization of HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 and p56lck together with impairment of T cell activation. J Immunol 149:285–294
Zal T, Weiss S, Mellor A, Stockinger B (1996) Expression of a second receptor rescues self-specific T cells from thymic deletion and allows activation of autoreactive effector function. Proc Natl Acad Sci USA 93:9102–9107
Acknowledgments
Jurkat-HXBc2(4) and Jurkat-522F/Y cells were obtained from Dr. Joseph Sodroski, and Jurkat Clone E6-1 cells from ATCC (Dr. Arthur Weiss), through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH. This work was supported by Consejo Nacional de Ciencia y Tecnología of México (CONACYT), grant 61425 and the Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México, grant IN229307. Evelyn Rivera-Toledo and Nayali López-Balderas were recipients of a fellowship from CONACYT. We appreciate the expert technical assistance of Carlos Castellanos with cell sorting.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
E. Rivera-Toledo and N. López-Balderas contributed equally to this work and are listed as co-first authors.
Rights and permissions
About this article
Cite this article
Rivera-Toledo, E., López-Balderas, N., Huerta, L. et al. Decreased CD4 and wide-ranging expression of other immune receptors after HIV-envelope-mediated formation of syncytia in vitro. Arch Virol 155, 1205–1216 (2010). https://doi.org/10.1007/s00705-010-0704-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-010-0704-2